SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 22, 2026

ATRC

AtriCure, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $227K total
Actionable Insight • Neutral

The insider cluster is routine and non-informative. The director grants are standard compensation, and the small sales are likely liquidity-driven. No actionable signal for traders, monitor upcoming quarterly earnings for any fundamental changes.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$28.29
T+0 close · May 22, 2026 · via day close
Latest settled
+61.75%
T+60 · $45.76
Vs SPY
+58.56%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 22 $28.29entry
  2. T+1 · 6mo ago +1.84%α +1.25% · $28.81
  3. T+5 · 6mo ago −6.40%α −8.07% · $26.48
  4. T+20 · 5mo ago −1.01%α +0.41% · $28.01
  5. T+60 · 3mo ago +61.75%α +58.56% · $45.76
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two AtriCure insiders sold a total of $227K in open-market sales over a 7-day window, representing 0.015% of the $1.5B market cap. The sales are trivial relative to company size and are accompanied by a large director grant of 6,144 shares each to 8 directors on May 18, which is a non-cash event. The cluster is dominated by non-cash grants and a single small sale by a director, with no C-suite selling, the signal is negligible.

Key Financial Metrics

Direction
selling
Total Value
$227.0K
Insiders
2

Key Facts

  • Total open-market sales: $227K (0.015% of $1.5B market cap)
  • 8 directors received non-cash grants of 6,144 shares each on May 18 ($0 value)
  • Only 2 insiders sold: Director Prange Karen ($86K) and CSO Doraiswamy Vinayak ($141K)
  • No C-suite executives (CEO/CFO) sold in the cluster
  • Sales are well below the 0.1% of market cap threshold for materiality

Financial Impact

Total insider sales of $227K represent 0.015% of market cap, immaterial

dilution

Risk Factors

  • No material insider selling risk identified

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
81% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ATRC-1779454682932

US Market Status

Market Closed · Opens in 7h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 22, 2026